A detailed history of Pathstone Holdings, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 98,605 shares of AMGN stock, worth $26 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
98,605
Previous 96,911 1.75%
Holding current value
$26 Million
Previous $30.3 Million 4.93%
% of portfolio
0.14%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $524,089 - $571,521
1,694 Added 1.75%
98,605 $31.8 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $83,029 - $100,901
316 Added 0.33%
96,911 $30.3 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $2.73 Million - $3.29 Million
10,143 Added 11.73%
96,595 $27.5 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $22.1 Million - $24.9 Million
86,452 New
86,452 $24.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.